当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:669.65亿  总市值:844.12亿
流通股本:21.18亿   总股本:26.70亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润21.00亿元,每股收益0.64元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益6031510.84万元,未分配利润2741251.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产11882793.71万元,负债5851282.87万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入19,514,431,849.599,420,322,797.3441,067,195,862.5930,911,889,002.9
营业总成本18,904,362,502.049,130,342,151.6839,397,511,520.6429,362,812,762.85
其他经营收益
营业利润2,761,208,390.861,358,771,228.344,245,103,909.313,107,588,817.82
利润总额2,718,481,583.081,347,541,972.014,169,281,679.723,071,565,885.4
净利润2,100,210,564.8941,566,276.853,512,440,3852,518,517,637.46
每股收益
其他综合收益-32,659,264.99-110,471,546.9543,142,250.33-213,927,299.31
综合收益总额2,067,551,299.81831,094,729.93,555,582,635.332,304,590,338.15
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计34,342,267,603.1934,438,609,708.9334,491,060,582.7334,527,299,352.05
非流动资产:
非流动资产合计84,485,669,451.9183,551,879,181.1682,969,506,766.5480,737,462,405.09
资产总计118,827,937,055.1117,990,488,890.09117,460,567,349.27115,264,761,757.14
流动负债:
流动负债合计36,023,336,557.9735,500,536,915.2537,452,669,252.7937,517,582,094.37
非流动负债:
非流动负债合计22,489,492,119.0321,640,050,046.7620,074,169,184.1618,552,575,493.14
负债合计58,512,828,67757,140,586,962.0157,526,838,436.9556,070,157,587.51
所有者权益(或股东权益):
归属于母公司股东权益合计47,397,623,662.6747,923,631,569.9547,261,106,860.7347,301,473,095.24
股东权益合计60,315,108,378.160,849,901,928.0859,933,728,912.3259,194,604,169.63
负债和股东权益合计118,827,937,055.1117,990,488,890.09117,460,567,349.27115,264,761,757.14
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计21,388,993,511.9610,431,224,855.4743,172,147,821.7731,551,927,328.39
经营活动现金流出小计19,254,993,017.659,375,544,977.0238,695,166,559.5528,565,289,973.22
经营活动产生的现金流量净额2,134,000,494.311,055,679,878.454,476,981,262.222,986,637,355.17
投资活动产生的现金流量:
投资活动现金流入小计2,012,663,450.931,275,324,161.382,405,322,190.851,823,762,368.12
投资活动现金流出小计2,872,400,465.891,460,415,546.786,018,645,562.074,263,474,836.99
投资活动产生的现金流量净额-859,737,014.96-185,091,385.4-3,613,323,371.22-2,439,712,468.87
筹资活动产生的现金流量:
筹资活动现金流入小计16,848,567,870.256,711,769,738.5833,369,274,946.323,965,139,058.31
筹资活动现金流出小计18,308,768,144.077,345,397,027.4234,371,861,283.6624,467,428,471
筹资活动产生的现金流量净额-1,460,200,273.82-633,627,288.84-1,002,586,337.36-502,289,412.69
汇率变动对现金及现金等价物的影响9,762,529.48,912,313.0327,989,327.43-69,635,970.14
现金及现金等价物净增加额-176,174,265.07245,873,517.24-110,939,118.93-25,000,496.53
期末现金及现金等价物余额9,215,275,522.049,637,323,304.359,391,449,787.119,477,388,409.51
补充资料:
现金及现金等价物的净增加额-176,174,265.07--110,939,118.93-
最新报告期:2025-09-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券杨松1.271.501.792025-09-14
中信证券陈竹1.251.481.792025-09-01
中金公司俞波,张琎1.301.56--2025-08-28
中国银河程培,宋丽莹1.241.451.752025-08-26
TOP↑